Effect of statin therapy on vaspin levels in type 2 diabetic patients
Sayer I Al-Azzam,1 Karem H Alzoubi,1 Jaafar Abu Abeeleh,2 Nizar M Mhaidat,1 Mahmoud Abu-Abeeleh31Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, 2Department of Pharmacy, Royal Medical Services, Amman, 3Department of Surgery, Division of Cardi...
Enregistré dans:
Auteurs principaux: | Al-Azzam SI, Alzoubi KH, Abu Abeeleh J, Mhaidat NM, Abu-Abeeleh M |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/eb835243a019475a80fd6e5a9c9de0e3 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Possible involvement of ROS generation in vorinostat pretreatment induced enhancement of the antibacterial activity of ciprofloxacin
par: Masadeh MM, et autres
Publié: (2017) -
The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapies
par: Davies M, et autres
Publié: (2016) -
Effects of irbesartan on serum uric acid levels in patients with hypertension and diabetes
par: Nakamura M, et autres
Publié: (2014) -
Neuropeptide Y: a potential theranostic biomarker for diabetic peripheral neuropathy in patients with type-2 diabetes
par: Noo Ree Cho, et autres
Publié: (2021) -
Detemir as a once-daily basal insulin in type 2 diabetes
par: Nelson SE
Publié: (2011)